Lonza aims to make ingredients for 400 mln doses of Moderna's COVID vaccine annually

Daily Mail on New Hampshire

Nov 16, 2020

ZURICH, Nov 16 (Reuters) - Swiss contract drug manufacturer Lonza's plants in the United States and Switzerland are due to make ingredients for 400 million...